US 6486166
Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infections
expired A61KA61K31/00A61K31/52
Quick answer
US patent 6486166 (Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infections) held by The Board of Regents of the University of Texas expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas
- Grant date
- Tue Nov 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/00, A61K31/52, A61P, A61P31/20